{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T23:59:45Z","timestamp":1775519985372,"version":"3.50.1"},"reference-count":18,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T00:00:00Z","timestamp":1536278400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0201005","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T17:31:52Z","timestamp":1536341512000},"page":"e0201005","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9685-9183","authenticated-orcid":true,"given":"John J.","family":"Bissler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Nonomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klemens","family":"Budde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard A.","family":"Zonnenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Fischereder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Voi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Laure","family":"Louveau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Herbst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Martina","family":"Bebin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Curatolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Zonta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Belousova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,9,7]]},"reference":[{"key":"ref1","article-title":"Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patients","author":"S Brakemeier","year":"2016","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"H Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2214\/AJR.14.14255","article-title":"Differentiation of Sporadic Versus Tuberous Sclerosis Complex-Associated Angiomyolipoma","volume":"205","author":"RA Rabenou","year":"2015","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"JJ Bissler","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1464-410X.2004.05046.x","article-title":"An epidemiological study of renal pathology in tuberous sclerosis complex","volume":"94","author":"FJ O'Callaghan","year":"2004","journal-title":"BJU Int"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eururo.2016.01.048","article-title":"Natural History of Renal Angiomyolipoma (AML): Most Patients with Large AMLs >4cm Can Be Offered Active Surveillance as an Initial Management Strategy","volume":"70","author":"JR Bhatt","year":"2016","journal-title":"Eur Urol"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1148\/radiology.197.3.7480725","article-title":"Renal angiomyolipoma: growth followed up with CT and\/or US","volume":"197","author":"L Lemaitre","year":"1995","journal-title":"Radiology"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/S0022-5347(17)35895-0","article-title":"The natural history of renal angiomyolipoma","volume":"150","author":"MS Steiner","year":"1993","journal-title":"J Urol"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.crad.2005.01.009","article-title":"Tuberose sclerosis complex: analysis of growth rates aids differentiation of renal cell carcinoma from atypical or minimal-fat-containing angiomyolipoma","volume":"60","author":"U Patel","year":"2005","journal-title":"Clin Radiol"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1053\/j.ajkd.2011.10.013","article-title":"Tuberous sclerosis complex-associated angiomyolipomas: focus on mTOR inhibition","volume":"59","author":"K Budde","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"DA Krueger","year":"2013","journal-title":"Pediatr Neurol"},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"e0180939","DOI":"10.1371\/journal.pone.0180939","article-title":"Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study","volume":"12","author":"JJ Bissler","year":"2017","journal-title":"PLoS One"},{"issue":"9869","key":"ref13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"JJ Bissler","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4329\/wjr.v8.i3.308","article-title":"Angiographic and volumetric effects of mammalian target of rapamycin inhibitors on angiomyolipomas in tuberous sclerosis","volume":"8","author":"RA Sheth","year":"2016","journal-title":"World J Radiol"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ndt\/gfv249","article-title":"Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial","volume":"31","author":"JJ Bissler","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"19","key":"ref16","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"DA Krueger","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"e757","DOI":"10.1016\/S1569-9056(16)60759-5","article-title":"Everolimus for Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex or Sporadic Lymphangioleiomyomatosis: Final Long-term Results From EXIST-2","volume":"15","author":"JJ Bissler","year":"2016","journal-title":"Eur Urol Supplements"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1148\/radiol.2251011477","article-title":"Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture","volume":"225","author":"K Yamakado","year":"2002","journal-title":"Radiology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0201005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:05:41Z","timestamp":1588968341000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0201005"}},"subtitle":[],"editor":[{"given":"Kathrin","family":"Eller","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,9,7]]},"references-count":18,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0201005","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,7]]}}}